Cargando…
Efficient Induction of Antigen-Specific CD8(+) T-Cell Responses by Cationic Peptide-Based mRNA Nanoparticles
A major determinant for the success of mRNA-based vaccines is the composition of the nanoparticles (NPs) used for formulation and delivery. Cationic peptides represent interesting candidate carriers for mRNA, since they have been shown to efficiently deliver nucleic acids to eukaryotic cells. mRNA N...
Autores principales: | D’haese, Sigrid, Laeremans, Thessa, den Roover, Sabine, Allard, Sabine D., Vanham, Guido, Aerts, Joeri L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321026/ https://www.ncbi.nlm.nih.gov/pubmed/35890284 http://dx.doi.org/10.3390/pharmaceutics14071387 |
Ejemplares similares
-
Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality
por: Laeremans, Thessa, et al.
Publicado: (2023) -
Unveiling the intricacies of gene delivery: Caveolae-mediated endocytosis induces efficient mRNA delivery in slow-dividing cells
por: den Roover, Sabine, et al.
Publicado: (2023) -
Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure
por: Schober, Rafaëla, et al.
Publicado: (2023) -
iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
por: de Jong, Wesley, et al.
Publicado: (2019) -
Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
por: de Jong, Wesley, et al.
Publicado: (2019)